A case of rofecoxib-associated Stevens-Johnson syndrome with corneal and conjunctival changes

Cornea

Volumn 23, Issue 7, 2004, Pages 736-737

  Goldberg, D ^a   Panigrahi, D ^a   Barazi, M ^a   Abelson, M ^b   Butrus, S ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; LATANOPROST; PREDNISOLONE ACETATE; PREDNISONE; ROFECOXIB;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CASE REPORT; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; CORNEA DISEASE; CORNEA MELTING; CORNEA NEOVASCULARIZATION; ECTROPION; EPISCLERITIS; ERYTHEMA; FEMALE; HUMAN; PRIORITY JOURNAL; RASH; SCAR FORMATION; STEVENS JOHNSON SYNDROME; SYMBLEPHARON; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRALGIA; CONJUNCTIVA; CORNEA; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; LACTONES; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; SULFONES;

EID: 4744374370     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000126330.77228.a3     Document Type: Article

References (5)

1. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-1285.
3. Powers WJ, Ghoraishi M, Merayo-Lloves J, et al. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology. 1995;102:1669-1676.
4. Bell MJ, Bishara LD. A case of Stevens-Johnson syndrome associated with oxaprozin therapy. J Rheumatol. 1998;25:2026-2028.
5. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433-442.